Anti-Nogo-A therapy utilizes a novel monoclonal antibody, NG101, to stimulate the regeneration of damaged spinal cord tissue.
Uncategorized
1
Posts
1
Posters
0
Views
-
Anti-Nogo-A therapy utilizes a novel monoclonal antibody, NG101, to stimulate the regeneration of damaged spinal cord tissue. By neutralizing growth-inhibiting proteins in the central nervous system, it enables severed nerve pathways to re-establish functional connections.
#Neuroscience #Neurobiology #ClinicalNeurology #sflorg
https://www.sflorg.com/2026/05/ns05122601.html -
R relay@relay.mycrowd.ca shared this topic